Stock Comparison
TECH vs VRTX
Bio-Techne Corp and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$11.27B
$123.94B
P/E (TTM)
103.3
28.5
Forward P/E
34.5
25.7
Price/Sales
9.3
9.9
Price/Book
5.4
6.1
EV/EBITDA
44.1
23.2
Dividend Yield
0.44%
—
Profitability
Net Margin
9.05%
35.40%
Operating Margin
12.70%
38.97%
Return on Equity
5.34%
23.50%
Return on Assets
7.45%
11.90%
Growth (YoY)
Revenue Growth
-1.50%
12.50%
Earnings Growth
128.60%
8.00%
Price & Risk
Beta
1.3
0.3
52-Week High
$72.29
$529.65
52-Week Low
$43.22
$376.62
Analyst Target
$69.73
$559.28
Compare TECH and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.